CHEK2 and thyroid cancer: The CHEK2 missense p.I157T (c.470T>C) germline mutation, which was previously reported to increase the risk of breast, colon, kidney, prostate, and thyroid cancers [4], is also associated with adult granulosa cell tumors (AGCTs).